BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 18424712)

  • 21. E2f2 induces cone photoreceptor apoptosis independent of E2f1 and E2f3.
    Chen D; Chen Y; Forrest D; Bremner R
    Cell Death Differ; 2013 Jul; 20(7):931-40. PubMed ID: 23558950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of E2F-mediated transcription by p202.
    Choubey D; Li SJ; Datta B; Gutterman JU; Lengyel P
    EMBO J; 1996 Oct; 15(20):5668-78. PubMed ID: 8896460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic lupus erythematosus and increased risk to develop B cell malignancies: role of the p200-family proteins.
    Veeranki S; Choubey D
    Immunol Lett; 2010 Sep; 133(1):1-5. PubMed ID: 20599558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Divergent siblings: E2F2 and E2F4 but not E2F1 and E2F3 induce DNA synthesis in cardiomyocytes without activation of apoptosis.
    Ebelt H; Hufnagel N; Neuhaus P; Neuhaus H; Gajawada P; Simm A; Müller-Werdan U; Werdan K; Braun T
    Circ Res; 2005 Mar; 96(5):509-17. PubMed ID: 15718499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The TRAF-interacting protein (TRAIP) is a novel E2F target with peak expression in mitosis.
    Chapard C; Hohl D; Huber M
    Oncotarget; 2015 Aug; 6(25):20933-45. PubMed ID: 26369285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors.
    Shen Q; Uray IP; Li Y; Krisko TI; Strecker TE; Kim HT; Brown PH
    Oncogene; 2008 Jan; 27(3):366-77. PubMed ID: 17637753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The gene encoding p202, an interferon-inducible negative regulator of the p53 tumor suppressor, is a target of p53-mediated transcriptional repression.
    D'Souza S; Xin H; Walter S; Choubey D
    J Biol Chem; 2001 Jan; 276(1):298-305. PubMed ID: 11013253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of an interferon-inducible protein (p202) to the retinoblastoma protein.
    Choubey D; Lengyel P
    J Biol Chem; 1995 Mar; 270(11):6134-40. PubMed ID: 7890747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. JPO1/CDCA7, a novel transcription factor E2F1-induced protein, possesses intrinsic transcriptional regulator activity.
    Goto Y; Hayashi R; Muramatsu T; Ogawa H; Eguchi I; Oshida Y; Ohtani K; Yoshida K
    Biochim Biophys Acta; 2006; 1759(1-2):60-8. PubMed ID: 16580749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Division and apoptosis of E2f-deficient retinal progenitors.
    Chen D; Pacal M; Wenzel P; Knoepfler PS; Leone G; Bremner R
    Nature; 2009 Dec; 462(7275):925-9. PubMed ID: 20016601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A role for E2F activities in determining the fate of Myc-induced lymphomagenesis.
    Rempel RE; Mori S; Gasparetto M; Glozak MA; Andrechek ER; Adler SB; Laakso NM; Lagoo AS; Storms R; Smith C; Nevins JR
    PLoS Genet; 2009 Sep; 5(9):e1000640. PubMed ID: 19749980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. E2F1 and E2F2 prevent replicative stress and subsequent p53-dependent organ involution.
    Iglesias-Ara A; Zenarruzabeitia O; Buelta L; Merino J; Zubiaga AM
    Cell Death Differ; 2015 Oct; 22(10):1577-89. PubMed ID: 25656653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcription factor compensation during mammary gland development in E2F knockout mice.
    To B; Andrechek ER
    PLoS One; 2018; 13(4):e0194937. PubMed ID: 29617434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subcellular localization and mechanisms of nucleocytoplasmic distribution of p202, an interferon-inducible candidate for lupus susceptibility.
    Choubey D; Pramanik R; Xin H
    FEBS Lett; 2003 Oct; 553(3):245-9. PubMed ID: 14572632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ifi202, an IFN-inducible candidate gene for lupus susceptibility in NZB/W F1 mice, is a positive regulator for NF-kappaB activation in dendritic cells.
    Yamauchi M; Hashimoto M; Ichiyama K; Yoshida R; Hanada T; Muta T; Komune S; Kobayashi T; Yoshimura A
    Int Immunol; 2007 Aug; 19(8):935-42. PubMed ID: 17702989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell proliferation in the absence of E2F1-3.
    Wenzel PL; Chong JL; Sáenz-Robles MT; Ferrey A; Hagan JP; Gomez YM; Rajmohan R; Sharma N; Chen HZ; Pipas JM; Robinson ML; Leone G
    Dev Biol; 2011 Mar; 351(1):35-45. PubMed ID: 21185283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Interaction of E2F/Rb family members with factor binding to co-repressor element on B-myb and E2F1 promoters].
    Nakajima Y
    Kokubyo Gakkai Zasshi; 1998 Jun; 65(2):172-88. PubMed ID: 9711036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p202, an interferon-inducible negative regulator of cell growth, is a target of the adenovirus E1A protein.
    Xin H; D'Souza S; Fang L; Lengyel P; Choubey D
    Oncogene; 2001 Oct; 20(47):6828-39. PubMed ID: 11687962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between E2F family members and tumor growth in colorectal adenocarcinomas: A comparative immunohistochemical study of 100 cases.
    Xanthoulis A; Kotsinas A; Tiniakos D; Fiska A; Tentes AA; Kyroudi A; Kittas C; Gorgoulis V
    Appl Immunohistochem Mol Morphol; 2014 Jul; 22(6):471-7. PubMed ID: 22688350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparing effects of CDK inhibition and E2F1/2 ablation on neuronal cell death pathways in vitro and after traumatic brain injury.
    Aubrecht TG; Faden AI; Sabirzhanov B; Glaser EP; Roelofs BA; Polster BM; Makarevich O; Stoica BA
    Cell Death Dis; 2018 Nov; 9(11):1121. PubMed ID: 30401820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.